Caetano Padial Sabino

Caetano Padial Sabino has a strong background in research and development, with experience in various scientific roles. Currently, they are working as the Director of Research and Development at Ondine Biomedical Inc. Caetano previously served as a Principal Scientist and Scientific Consultant at the same company. Prior to that, they were a Postdoctoral Researcher at the Nuclear and Energy Research Institute.

In addition to their research experience, Caetano has entrepreneurial experience as well. Caetano was the CEO and Founder of Biolambda, a company focused on consultancy in the biotechnology field. Caetano also worked as a Consultant at Biolambda.

Caetano began their career as an undergraduate research student at the Instituto de Ciências Biomédicas da Universidade de São Paulo and the Center for Lasers and Applications, where they conducted research in the field of biomedical engineering and biophysics.

Caetano also gained international exposure by working as a Visiting Student at the Massachusetts General Hospital.

Overall, Caetano Padial Sabino has a diverse range of experience in research, development, consultancy, and entrepreneurship, making him a valuable asset in the scientific and biotechnology industries.

Caetano Padial Sabino earned a PhD in Pharmacy with a specialization in Pathophysiology and Toxicology from Faculdade de Ciências Farmacêuticas da USP, which they completed from 2016 to 2021. Prior to that, they obtained a BSc in Fundamental Health Sciences with a focus on Microbiology from USP - Universidade de São Paulo, graduating between 2011 and 2015. Additionally, they earned a BSc in Physics with a specialization in Biophotonics from USP - Universidade de São Paulo, which they completed from 2010 to 2012.